ERYTHROPLAKIA
Clinical trials for ERYTHROPLAKIA explained in plain language.
Never miss a new study
Get alerted when new ERYTHROPLAKIA trials appear
Sign up with your email to follow new studies for ERYTHROPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shining a new light on cancer: High-Tech mouth scans aim to catch disease early
Diagnosis OngoingThis study is testing new imaging tools that use special colored lights to look inside the mouth, aiming to spot pre-cancer or early cancer sooner than standard exams. It involves people at higher risk for oral cancer, such as those with white or red patches, a history of mouth i…
Matched conditions: ERYTHROPLAKIA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Common diabetes pill may stop mouth cancer before it starts
Prevention OngoingThis study is testing if metformin, a common diabetes medication, can prevent oral cancer in people who have suspicious red or white patches in their mouth. About 34 adult smokers or former smokers with these pre-cancerous patches will take either metformin or a placebo pill dail…
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Common diabetes pill tested to stop mouth cancer before it starts
Prevention OngoingThis study is testing whether metformin, a common diabetes medication, can help prevent oral cancer in people who have precancerous red or white patches in their mouth. Twenty-six participants with these high-risk lesions will take metformin pills daily for about 3 months. Resear…
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC